RGNX
REGENXBIO Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -25.0% ·
Aktienfluss -27.2% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | 0 | 31.71M | $379.43M | +8 | −8 |
| Q1 2026 | 78 | -5 | 30.64M | $255.01M | +3 | −8 |
| Q4 2025 | 83 | +2 | 30.25M | $435.60M | +2 | — |
| Q3 2025 | 14 | -1 | 26.58M | $256.50M | — | −1 |
| Q2 2025 | 12 | 0 | 15.85M | $130.14M | — | — |
| Q1 2025 | 9 | -3 | 5.03M | $35.96M | +1 | −4 |
| Q4 2024 | 12 | +4 | 6.91M | $53.43M | +4 | — |
| Q3 2024 | 7 | -3 | 1.79M | $18.80M | — | −3 |
| Q2 2024 | 10 | — | 2.06M | $24.11M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passiv) | 1.11M | +1.2% | $7.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 1.11M | +1.2% | $7.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passiv) | 1.07M | -51.2% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.03M | +75.5% | $7.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.03M | +75.5% | $7.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 620.60K | +2247.7% | $4.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 620.60K | +2247.7% | $4.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 620.60K | +2247.7% | $4.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 620.60K | +2247.7% | $4.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 620.60K | +2247.7% | $4.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 332.83K | -74.8% | $2.38M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 326.71K | -16.1% | $2.34M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 296.80K | +9.4% | $2.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 225.58K | Neu | $1.61M | 0.0% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 225.58K | Neu | $1.61M | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 26.20K | +9.6% | $188,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $1.61M | 0.0% |
| Marshall Wace | $1.61M | 0.0% |
Ausgestiegen
| Adage Capital Partners | $3.87M | war 0.0% |
| Norges Bank | $3.47M | war 0.0% |
| D. E. Shaw & Co. | $489,904 | war 0.0% |
| Point72 Asset Management | $1,546 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 177 Inhaber, 39.19M Anteile, $343.14M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.